First-line Pyrotinib in Advanced HER2-mutant Non-Small-cell Lung Cancer: a Patient-Centric Phase 2 Trial.
NATURE MEDICINE(2023)
关键词
Non-small-cell lung cancer,Phase II trials,Biomedicine,general,Cancer Research,Metabolic Diseases,Infectious Diseases,Molecular Medicine,Neurosciences
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要